Eckman, Emily
Laman, Jon D.
Fischer, Kael F.
Lopansri, Bert
Martins, Tom B.
Hill, Harry R.
Kriesel, John D. http://orcid.org/0000-0003-4861-7723
Funding for this research was provided by:
Stichting Zabawas
School of Medicine
Article History
Received: 5 March 2021
Revised: 22 April 2021
Accepted: 26 April 2021
First Online: 8 June 2021
Declarations
:
: The study was approved by the University of Utah Health Sciences Institutional Review Board (IRB), protocol IRB_47316.
: Each subject either signed an IRB-approved informed consent or had a legally authorized representative sign for them.
: Research subject DD-03 and his wife have specifically consented to the publication of his case details, including the identifying information provided in reference #20. The consent document was provided by and then approved by the University of Utah.
: The authors declare no competing interests. The work is protected by United States Provisional Patent Application #62785377, “Compositions and Methods Useful in Detecting and Treating Multiple Sclerosis and Other Demyelinating Diseases” filed by the University of Utah, December 28, 2018.